EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice

Patricia O. Prada; Eduardo R. Ropelle; Rosa H. Mourão; Claudio T. de Souza; Jose R. Pauli; Dennys E. Cintra; André Schenka; Silvana A. Rocco; Roberto Rittner; Kleber G. Franchini; José Vassallo; Lício A. Velloso; José B. Carvalheira; Mario J.A. Saad

doi:10.2337/db08-0506

EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice

Diabetes ◽

10.2337/db08-0506 ◽

2009 ◽

Vol 58 (12) ◽

pp. 2910-2919 ◽

Cited By ~ 47

Author(s):

Patricia O. Prada ◽

Eduardo R. Ropelle ◽

Rosa H. Mourão ◽

Claudio T. de Souza ◽

Jose R. Pauli ◽

...

Keyword(s):

Glucose Tolerance ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

High Fat Diet ◽

Insulin Action ◽

Kinase Inhibitor ◽

High Fat ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Expression of Concern. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185

Diabetes ◽

10.2337/db17-ec04a ◽

2017 ◽

Vol 66 (4) ◽

pp. 1098-1098 ◽

Cited By ~ 1

Author(s):

Patricia O. Prada ◽

Eduardo R. Ropelle ◽

Rosa H. Mourão ◽

Claudio T. de Souza ◽

Jose R. Pauli ◽

...

Keyword(s):

Glucose Tolerance ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

High Fat Diet ◽

Insulin Action ◽

Kinase Inhibitor ◽

High Fat ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185

Diabetes ◽

10.2337/db17-rt07a ◽

2017 ◽

Vol 66 (7) ◽

pp. 2059-2059

Author(s):

Patricia O. Prada ◽

Eduardo R. Ropelle ◽

Rosa H. Mourão ◽

Claudio T. de Souza ◽

Jose R. Pauli ◽

...

Keyword(s):

Glucose Tolerance ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

High Fat Diet ◽

Insulin Action ◽

Kinase Inhibitor ◽

High Fat ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Dual-agent molecular targeting of growth factor receptors in hepatocellular cancer: Combining anti-EGFR antibody with an EGFR tyrosine kinase inhibitor

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-920152 ◽

2005 ◽

Vol 43 (05) ◽

Author(s):

A Hüther ◽

M Höpfner ◽

D Schuppan ◽

H Scherübl

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Hepatocellular Cancer ◽

Growth Factor Receptors ◽

Molecular Targeting ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Egfr Antibody

Download Full-text

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Case Medical Research ◽

10.31525/ct1-nct04007835 ◽

2019 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Advanced Nsclc ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Nsclc Patients ◽

Egfr Tki

Download Full-text

O-247 Molecular mechanisms of sensitivity and resistance to the HER1/EGFR-tyrosine kinase inhibitor erlotinib (Tarceva™)

Lung Cancer ◽

10.1016/s0169-5002(03)91905-2 ◽

2003 ◽

Vol 41 ◽

pp. S72 ◽

Cited By ~ 6

Author(s):

Roman Perez-Soler ◽

Qun Dai ◽

Yi-He Ling ◽

Marie Lee ◽

Glenn Kroog ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Molecular Mechanisms ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-11-0048 ◽

2011 ◽

Vol 10 (6) ◽

pp. 1102-1112 ◽

Cited By ~ 113

Author(s):

Monika E. Hegi ◽

Annie-Claire Diserens ◽

Pierre Bady ◽

Yuta Kamoshima ◽

Mathilde C. M. Kouwenhoven ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Phase Ii ◽

Pathway Analysis ◽

Kinase Inhibitor ◽

Phase Ii Trial ◽

Preoperative Treatment ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

P3.01-073 TPX-0005 with an EGFR Tyrosine Kinase Inhibitor (TKI) Overcomes Innate Resistance in EGFR Mutant NSCLC

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1514 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2230

Author(s):

R. Rosell ◽

N. Karachaliou ◽

J.J. Cui ◽

I. Chaib ◽

J. Berenguer ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Innate Resistance ◽

Egfr Tyrosine Kinase ◽

Egfr Mutant

Download Full-text

EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.015 ◽

2021 ◽

Vol 16 (11) ◽

pp. 1793-1797

Author(s):

Sophie Stock-Martineau ◽

Frances A. Shepherd

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Line Treatment ◽

First Line ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan

Oncology Letters ◽

10.3892/ol.2019.10942 ◽

2019 ◽

Author(s):

Ching‑Hu Chung

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Clinical Outcomes ◽

Kinase Inhibitor ◽

Cancer Treatments ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

Oncogene ◽

10.1038/s41388-018-0517-4 ◽

2018 ◽

Vol 38 (9) ◽

pp. 1398-1409 ◽

Cited By ~ 15

Author(s):

Kimio Yonesaka ◽

Naoki Takegawa ◽

Satomi Watanabe ◽

Koji Haratani ◽

Hisato Kawakami ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Topoisomerase I ◽

Kinase Inhibitor ◽

Dna Topoisomerase I ◽

Antibody Drug Conjugate ◽

Egfr Tyrosine Kinase Inhibitor ◽

Dna Topoisomerase ◽

Egfr Tyrosine Kinase ◽

Antibody Drug

Download Full-text